Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.
A third of youths in New York City foster care identify as LGBTQAI+, finds a study by Columbia researcher Theo Sandfort. But why so many gender diverse youths end up in foster care is unclear.
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
For mental health professionals, teletherapy can feel like it’s “one step removed,” although studies suggest it produces outcomes statistically equivalent to face-to-face treatment.
In a webinar co-sponsored by Columbia's School of Journalism, Columbia psychiatrists discuss how inequalities in mental health care have had a tangible impact on Black Americans for generations.
A panel discussion held in observance of National Physician Suicide Awareness Day on Sept. 17 highlighted the legacy of Dr. Lorna Breen and the ongoing fight to curb physician suicide.
Columbia psychiatrists are developing a financial wellness program to help New Yorkers buffer the mental health impact of unemployment, financial loss, and eviction.
Two Columbia psychologists write that practicing acceptance of our current reality—not toxic positivity—is a key way to cope with the mental health effects of the pandemic.
Daily social media use is not a strong or consistent risk factor for depressive symptoms among adolescents, according to a new study by Columbia University Mailman School of Public Health researchers.